Sunday, 5 October 2025
  
Login

Australia's most trusted
source of pharma news

Sunday, 05 October 2025
News

10 new drugs hit TGA review list

Posted 1 October 2025 AM

A bumper list of 21 drugs has landed at the TGA, with 10 of those under evaluation, newcomers to the Australian market.

Sanofi's BTK inhibitor Cenrifki is being evaluated for use in adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS) to help slow down disability progression, after being granted priority review.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (25)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (2)

Devices (1)

Other (15)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.